Delivery Order SPE2DB22D1202-SPE2DB24FUWU8
Award Date 4/12/24
Potential Completion Date 5/3/24
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,295.05 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024, with a completion date of August 16, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of the pharmaceutical product RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML to the Defense Logistics Agency (DLA). The $2,775.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The contract, valued at $1,103.02, is a Delivery Order with a Firm Fixed Price pricing type awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 13, 2024 and was awarded on May 22, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award, valued at $2,295.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- This federal contract award is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The contract, valued at $4,590.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 12, 2024. The contract has a completion date of July 5, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a medical product. The contract, valued at $1,380.52, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The contract has an ultimate completion date of August 14, 2024, and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen is a well-established federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical supplies. The $4,590.10 contract has a performance period through March 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designations were used. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $1,195.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,010.52 firm-fixed-price delivery order is for the provision of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a prescription medication, with a completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product, with a firm-fixed price of $1,387.50 and a ceiling value of $1,387.50. The delivery order does not have a set-aside designation and is expected to be completed by August 13,...